These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10499613)

  • 1. Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer.
    Cher ML; de Oliveira JG; Beaman AA; Nemeth JA; Hussain M; Wood DP
    Clin Cancer Res; 1999 Sep; 5(9):2421-5. PubMed ID: 10499613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of prostate cells in bone marrow biopsies as a sign of micrometastasis in cancer patients.
    Murray NP; Calaf GM; Badínez L
    Oncol Rep; 2009 Mar; 21(3):571-5. PubMed ID: 19212613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
    Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
    BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
    Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
    Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
    Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
    Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients.
    Flatmark K; Bjørnland K; Johannessen HO; Hegstad E; Rosales R; Hårklau L; Solhaug JH; Faye RS; Søreide O; Fodstad Ø;
    Clin Cancer Res; 2002 Feb; 8(2):444-9. PubMed ID: 11839662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redefining micrometastasis in prostate cancer - a comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatectomy.
    Murray NP; Reyes E; Tapia P; Badinez L; Orellana N; Fuentealba C; Olivares R; Porcell J; Dueñas R
    Int J Mol Med; 2012 Oct; 30(4):896-904. PubMed ID: 22825050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
    Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
    Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer: flow cytometric methods for detection of bone marrow micrometastases.
    Hussain M; Kukuruga M; Biggar S; Sakr W; Cummings G; Ensley J
    Cytometry; 1996 Mar; 26(1):40-6. PubMed ID: 8809479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
    Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
    J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
    J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer.
    Berg A; Bruland ØS; Fosså SD; Nesland JM; Berner A; Schirmer C; Lilleby W
    Prostate; 2008 Nov; 68(15):1607-14. PubMed ID: 18655095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer.
    Bianco FJ; Wood DP; Gomes de Oliveira J; Nemeth JA; Beaman AA; Cher ML
    Prostate; 2001 Dec; 49(4):235-42. PubMed ID: 11746269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
    Bregni M; Fleischhauer K; Bernardi M; Pescarollo A; Guggiari E; Lunghi F; Deola S; Scaramuzza S; Re F; Setola E; Monari M; Mazzi B; Servida P; Corradini P; Peccatori J
    Bone Marrow Transplant; 2006 Feb; 37(3):311-5. PubMed ID: 16400340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen-producing cells in the bone marrow of a patient with early-stage prostate cancer.
    D'Amico AV; Matelski H; O'Leary M; Sussman B
    Urology; 1997 Feb; 49(2):279-82. PubMed ID: 9037298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The current status of molecular detection of micrometastatic prostate cancer cells].
    Deguchi T; Yang M; Yasuda M; Yokoi S; Nishino Y; Ehara H; Yamamoto N; Takahashi Y; Ishihara S
    Hinyokika Kiyo; 1999 Aug; 45(8):565-9. PubMed ID: 10500964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
    Köllermann J; Weikert S; Schostak M; Kempkensteffen C; Kleinschmidt K; Rau T; Pantel K
    J Clin Oncol; 2008 Oct; 26(30):4928-33. PubMed ID: 18794550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z; Wenlu S
    Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.